Skip to main content
SpringerLink
Log in

Pharmacological Management of Chronic Pelvic Pain in Women

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Chronic pelvic pain (CPP) is a multifaceted condition that often has both peripheral and central generators of pain. An understanding of neurobiology and neuropsychology of CPP should guide management. Successful treatment of CPP is typically multimodal, and pharmacologic treatment strategies include analgesics, hormonal suppression, anesthetics, antidepressants, membrane stabilizers, and anxiolytics. Evidence for these and other emerging pharmacologic therapies is presented in this article.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Howard FM. ACOG Practice Bulletin No. 51. Chronic pelvic pain. Obstet Gynecol. 2004;103:589–605.

    Article  Google Scholar 

  2. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87:321–7.

    Article  CAS  PubMed  Google Scholar 

  3. Gelbaya TA, El-Halwagy HE. Focus on primary care: chronic pelvic pain in women. Obstet Gynecol Surv. 2001;56:757–64.

    Article  CAS  PubMed  Google Scholar 

  4. Broder MS, Kanouse DE, Mittman BS, Bernstein SJ. The appropriateness of recommendations for hysterectomy. Obstet Gynecol. 2000;95:199–205.

    CAS  PubMed  Google Scholar 

  5. Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM, Marchbanks PA. Inpatient hysterectomy surveillance in the United States, 2000–2004. Am J Obstet Gynecol. 2008;198(34):e1–7.

    Google Scholar 

  6. Howard FM. The role of laparoscopy in chronic pelvic pain: promise and pitfalls. Obstet Gynecol Surv. 1993;48:357–87.

    Article  CAS  PubMed  Google Scholar 

  7. Howard FM. Surgical treatment of endometriosis. Obstet Gynecol Clin N Am. 2011;38:677–86.

    Article  Google Scholar 

  8. Howard FM. Chronic pelvic pain. Obstet Gynecol. 2003;101:594–611.

    PubMed  Google Scholar 

  9. As-Sanie S, Clevenger LA, Geisser ME, Williams DA, Roth RS. History of abuse and its relationship to pain experience and depression in women with chronic pelvic pain. Am J Obstet Gynecol. 2014;210(317):e1–8.

    Google Scholar 

  10. Anderson RU, Orenberg EK, Chan CA, Morey A, Flores V. Psychometric profiles and hypothalamic-pituitary-adrenal axis function in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2008;179:956–60.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524–34.

    Article  PubMed  Google Scholar 

  12. Benzon H, Raja SN, Fishman SE, Liu S, Cohen SP. Essentials of pain medicine. Elsevier Health Sciences. 2011;5-6, 201-204.

  13. Williams DA, Clauw DJ. Understanding fibromyalgia: lessons from the broader pain research community. J Pain. 2009;10:777–91.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152:S2–15.

    Article  PubMed  Google Scholar 

  15. Tracey I, Bushnell MC. How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain. 2009;10:1113–20.

    Article  PubMed  Google Scholar 

  16. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311:1547–55.

    Article  PubMed  CAS  Google Scholar 

  17. Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG. Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril. 1996;65:299–304.

    Article  CAS  PubMed  Google Scholar 

  18. Brawn J, Morotti M, Zondervan KT, Becker CM, Vincent K. Central changes associated with chronic pelvic pain and endometriosis. Hum Reprod Update. 2014;20:737–47.

    Article  PubMed  PubMed Central  Google Scholar 

  19. As-Sanie S, Kim J, Schmidt-Wilcke T, Sundgren PC, Clauw DJ, Napadow V, et al. Functional connectivity is associated with altered brain chemistry in women with endometriosis-associated chronic pelvic pain. J Pain. 2016;17:1–13.

    Article  CAS  PubMed  Google Scholar 

  20. As-Sanie S, Harris RE, Napadow V, Kim J, Neshewat G, Kairys A, et al. Changes in regional gray matter volume in women with chronic pelvic pain: a voxel-based morphometry study. Pain. 2012;153:1006–14.

    Article  PubMed  PubMed Central  Google Scholar 

  21. As-Sanie S, Harris RE, Harte SE, Tu FF, Neshewat G, Clauw DJ. Increased pressure pain sensitivity in women with chronic pelvic pain. Obstet Gynecol. 2013;122:1047–55.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Malykhina AP. Neural mechanisms of pelvic organ cross-sensitization. Neuroscience. 2007;149:660–72.

    Article  CAS  PubMed  Google Scholar 

  23. Balasch J, Creus M, Fábregues F, Carmona F, Ordi J, Martinez-Román S, et al. Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study. Hum Reprod. 1996;11:387–91.

    Article  CAS  PubMed  Google Scholar 

  24. Porpora MG, Koninckx PR, Piazze J, Natili M, Colagrande S, Cosmi EV. Correlation between endometriosis and pelvic pain. J Am Assoc Gynecol Laparosc. 1999;6:429–34.

    Article  CAS  PubMed  Google Scholar 

  25. Alappattu MJ, Bishop MD. Psychological factors in chronic pelvic pain in women: relevance and application of the fear-avoidance model of pain. Phys Ther. 2011;91:1542–50.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kwon JK, Chang IH. Pain, catastrophizing, and depression in chronic prostatitis/chronic pelvic pain syndrome. Int Neurourol J. 2013;17:48–58.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Meltzer-Brody S, Leserman J. Psychiatric comorbidity in women with chronic pelvic pain. CNS Spectr. 2011;16:29–35.

    Article  PubMed  Google Scholar 

  28. Koutantji M, Pearce SA, Oakley DA. The relationship between gender and family history of pain with current pain experience and awareness of pain in others. Pain. 1998;77:25–31.

    Article  CAS  PubMed  Google Scholar 

  29. Angst J, Gamma A, Gastpar M, Lépine J-P, Mendlewicz J, Tylee A. Gender differences in depression. Eur Arch Psychiatry Clin Neurosci. 2002;252:201–9.

    Article  CAS  PubMed  Google Scholar 

  30. Peters ML. Emotional and cognitive influences on pain experience. Mod Trends Pharmacopsychiatr. 2015;30:138–52.

    Article  Google Scholar 

  31. Phillips ML, Gregory LJ, Cullen S, et al. The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation. Brain. 2003;126:669–84.

    Article  PubMed  Google Scholar 

  32. Campbell LC, Clauw DJ, Keefe FJ. Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry. 2003;54:399–409.

    Article  PubMed  Google Scholar 

  33. Williams DA. The importance of psychological assessment in chronic pain. Curr Opin Urol. 2013;23:554–9.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433–45.

    Article  PubMed  Google Scholar 

  35. Read J, Cartwright C, Gibson K, Shiels C, Haslam N. Beliefs of people taking antidepressants about causes of depression and reasons for increased prescribing rates. J Affect Disord. 2014;168:236–42.

    Article  PubMed  Google Scholar 

  36. Atkinson JH, Slater MA, Williams RA, Zisook S, Patterson TL, Grant I, et al. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain. 1998;76:287–96.

    Article  CAS  PubMed  Google Scholar 

  37. Romão APMS, Gorayeb R, Romão GS, Poli-Neto OB, dos Reis FJC, Rosa-e-Silva JC, et al. High levels of anxiety and depression have a negative effect on quality of life of women with chronic pelvic pain. Int J Clin Pract. 2009;63:707–11.

    Article  PubMed  Google Scholar 

  38. Miller-Matero LR, Saulino C, Clark S, Bugenski M, Eshelman A, Eisenstein D. When treating the pain is not enough: a multidisciplinary approach for chronic pelvic pain. Arch Womens Ment Health. 2016;19:349–54.

    Article  PubMed  Google Scholar 

  39. Zondervan KT, Yudkin PL, Vessey MP, Jenkinson CP, Dawes MG, Barlow DH, et al. The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br J Gen Pract. 2001;51:541–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Mifflin K, Benson C, Kerr B, Aricioglu F, Cetin M, Dursun S, et al. Involvement of neuroactive steroids in pain, depression and anxiety. Mod Trends Pharmacopsychiatr. 2015;30:94–102.

    Article  Google Scholar 

  41. Merkes M. Mindfulness-based stress reduction for people with chronic diseases. Aust J Prim Health. 2010;16:200–10.

    Article  PubMed  Google Scholar 

  42. Kasckow JW, Baker D, Geracioti TD Jr. Corticotropin-releasing hormone in depression and post-traumatic stress disorder. Peptides. 2001;22:845–51.

    Article  CAS  PubMed  Google Scholar 

  43. Lariviere WR, Fiorenzani P, Ceccarelli I, Massafra C, Sorda G, Di Canio C, et al. Central CRH administration changes formalin pain responses in male and female rats. Brain Res. 2011;1383:128–34.

    Article  CAS  PubMed  Google Scholar 

  44. Fukudo S. Stress and visceral pain: focusing on irritable bowel syndrome. Pain. 2013;154(Suppl 1):S63–70.

    Article  CAS  PubMed  Google Scholar 

  45. McCall JG, Al-Hasani R, Siuda ER, Hong DY, Norris AJ, Ford CP, et al. CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety. Neuron. 2015;87:605–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Wingenfeld K, Hellhammer DH, Schmidt I, Wagner D, Meinlschmidt G, Heim C. HPA axis reactivity in chronic pelvic pain: association with depression. J Psychosom Obstet Gynaecol. 2009;30:282–6.

    Article  PubMed  Google Scholar 

  47. Quiñones M, Urrutia R, Torres-Reverón A, Vincent K, Flores I. Anxiety, coping skills and hypothalamus-pituitary-adrenal (HPA) axis in patients with endometriosis. J Reprod Biol Health. 2015. doi:10.7243/2054-0841-3-2 (Epub 11 Jun 2015).

  48. Pierce AN, Christianson JA. Stress and chronic pelvic pain. Prog Mol Biol Transl Sci. 2015;131:509–35.

    Article  PubMed  Google Scholar 

  49. Paras ML, Murad MH, Chen LP, Goranson EN, Sattler AL, Colbenson KM, et al. Sexual abuse and lifetime diagnosis of somatic disorders: a systematic review and meta-analysis. JAMA. 2009;302:550–61.

    Article  CAS  PubMed  Google Scholar 

  50. Pennebaker JW, Susman JR. Disclosure of traumas and psychosomatic processes. Soc Sci Med. 1988;26:327–32.

    Article  CAS  PubMed  Google Scholar 

  51. Cosic A, Ferhatovic L, Banozic A, Kraljevic S, Maric A, Sapunar D, et al. Pain catastrophizing changes during the menstrual cycle. Psychol Health Med. 2013;18:735–41.

    Article  PubMed  Google Scholar 

  52. Turner JA, Jensen MP, Romano JM. Do beliefs, coping, and catastrophizing independently predict functioning in patients with chronic pain? Pain. 2000;85:115–25.

    Article  CAS  PubMed  Google Scholar 

  53. Keefe FJ, Brown GK, Wallston KA, Caldwell DS. Coping with rheumatoid arthritis pain: catastrophizing as a maladaptive strategy. Pain. 1989;37:51–6.

    Article  CAS  PubMed  Google Scholar 

  54. Davis MC, Zautra AJ, Wolf LD, Tennen H, Yeung EW. Mindfulness and cognitive–behavioral interventions for chronic pain: differential effects on daily pain reactivity and stress reactivity. J Consult Clin Psychol. 2015;83:24.

    Article  PubMed  Google Scholar 

  55. Flink IK, Boersma K, Linton SJ. Changes in catastrophizing and depressed mood during and after early cognitive behaviorally oriented interventions for pain. Cogn Behav Ther. 2014;43:332–41.

    Article  PubMed  Google Scholar 

  56. Ludäscher P, von Kalckreuth C, Parzer P, Kaess M, Resch F, Bohus M, et al. Pain perception in female adolescents with borderline personality disorder. Eur Child Adolesc Psychiatry. 2015;24:351–7.

    Article  PubMed  Google Scholar 

  57. Schmahl C, Greffrath W, Baumgärtner U, Schlereth T, Magerl W, Philipsen A, et al. Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: laser-evoked potentials, spatial discrimination of noxious stimuli, and pain ratings. Pain. 2004;110:470–9.

    Article  PubMed  Google Scholar 

  58. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015;(2):CD001751.

  59. Jarrell JF, Vilos GA, Allaire C, et al. Consensus guidelines for the management of chronic pelvic pain. J Obstet Gynaecol Can. 2005;27:781–826.

    Article  PubMed  Google Scholar 

  60. Jabbour HN, Kelly RW, Fraser HM, Critchley HOD. Endocrine regulation of menstruation. Endocr Rev. 2006;27:17–46.

    Article  CAS  PubMed  Google Scholar 

  61. García Rodríguez LA. Nonsteroidal antiinflammatory drugs, ulcers and risk: a collaborative meta-analysis. Semin Arthritis Rheum. 1997;26:16–20.

    Article  PubMed  Google Scholar 

  62. Makin AJ, Williams R. Acetaminophen-induced hepatotoxicity: predisposing factors and treatments. Adv Intern Med. 1997;42:453–83.

    CAS  PubMed  Google Scholar 

  63. Baranowski AP, Lee J, Price C, Hughes J. Pelvic pain: a pathway for care developed for both men and women by the British Pain Society. Br J Anaesth. 2014;112:452–9.

    Article  CAS  PubMed  Google Scholar 

  64. Healy JR, Bezawada P, Shim J, Jones JW, Kane MA, MacKerell AD Jr, et al. Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities. ACS Chem Neurosci. 2013;4:1256–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services. Guideline for prescribing opioids for chronic pain. J Pain Palliat Care Pharmacother. 2016;30:138–40.

    Article  Google Scholar 

  66. Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol. 2011;118:691–705.

    Article  CAS  PubMed  Google Scholar 

  67. Hornstein MD, Surrey ES, Weisberg GW, Casino LA. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. Obstet Gynecol. 1998;91:16–24.

    Article  CAS  PubMed  Google Scholar 

  68. Sagsveen M, Farmer JE, Prentice A, Breeze A. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev. 2003;(4):CD001297.

  69. The Cochrane Collaboration. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2010; 13-18.

  70. Selak V, Farquhar C, Prentice A, Singla A. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. 2007;(4):CD000068.

  71. Telimaa S, Puolakka J, Rönnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol. 1987;1:13–23.

    Article  CAS  PubMed  Google Scholar 

  72. Lavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Anesthesiol Clin. 2007;25:841–51, vii–iii.

  73. Srinivasan R, Greenbaum DS. Chronic abdominal wall pain: a frequently overlooked problem. Am J Gastroenterol. 2002;97:824–30.

    PubMed  Google Scholar 

  74. Labat JJ, Riant T, Lassaux A, Rioult B, Rabischong B, Khalfallah M, et al. Adding corticosteroids to the pudendal nerve block for pudendal neuralgia: a randomised, double-blind, controlled trial. BJOG. 2017;124(2):251–60.

    Article  CAS  PubMed  Google Scholar 

  75. Langford CF, Udvari Nagy S, Ghoniem GM. Levator ani trigger point injections: An underutilized treatment for chronic pelvic pain. Neurourol Urodyn. 2007;26:59–62.

    Article  PubMed  Google Scholar 

  76. Peloso P, Gross A, Haines T, Trinh K, Goldsmith CH, Burnie S, Cervical Overview Group. Medicinal and injection therapies for mechanical neck disorders. Cochrane Database Syst Rev. 2007;(3):CD000319.

  77. Scott NA, Guo B, Barton PM, Gerwin RD. Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review. Pain Med. 2009;10:54–69.

    Article  PubMed  Google Scholar 

  78. Hameroff SR, Crago BR, Blitt CD, Womble J, Kanel J. Comparison of bupivacaine, etidocaine, and saline for trigger-point therapy. Anesth Analg. 1981;60:752–5.

    Article  CAS  PubMed  Google Scholar 

  79. Vancaillie T, Eggermont J, Armstrong G, Jarvis S, Liu J, Beg N. Response to pudendal nerve block in women with pudendal neuralgia. Pain Med. 2012;13:596–603.

    Article  PubMed  Google Scholar 

  80. Rapkin AJ, McDonald JS, Morgan M. Multilevel local anesthetic nerve blockade for the treatment of vulvar vestibulitis syndrome. Am J Obstet Gynecol. 2008;198(41):e1–5.

    Google Scholar 

  81. Zoorob D, South M, Karram M, Sroga J, Maxwell R, Shah A, et al. A pilot randomized trial of levator injections versus physical therapy for treatment of pelvic floor myalgia and sexual pain. Int Urogynecol J. 2015;26:845–52.

    Article  PubMed  Google Scholar 

  82. Affaitati G, Fabrizio A, Savini A, Lerza R, Tafuri E, Costantini R, et al. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther. 2009;31:705–20.

    Article  CAS  PubMed  Google Scholar 

  83. Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003;102:84–7.

    CAS  PubMed  Google Scholar 

  84. Foster DC, Kotok MB, Huang L-S, Watts A, Oakes D, Howard FM, et al. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2010;116:583–93.

    Article  CAS  PubMed  Google Scholar 

  85. Tamano R, Ishida M, Asaki T, Hasegawa M, Shinohara S. Effect of spinal monoaminergic neuronal system dysfunction on pain threshold in rats, and the analgesic effect of serotonin and norepinephrine reuptake inhibitors. Neurosci Lett. 2016;615:78–82.

    Article  CAS  PubMed  Google Scholar 

  86. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012;(12):CD008242.

  87. An update on the drug treatment of neuropathic pain. Part 1: antidepressants. Drug Ther Bull. 2012;50:114–117.

  88. Godfrey RG. A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch Intern Med. 1996;156:1047–52.

    Article  CAS  PubMed  Google Scholar 

  89. Sator-Katzenschlager SM, Scharbert G, Kress HG, Frickey N, Ellend A, Gleiss A, et al. Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr. 2005;117:761–8.

    Article  CAS  PubMed  Google Scholar 

  90. Tofferi JK, Jackson JL, O’Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004;51:9–13.

    Article  CAS  PubMed  Google Scholar 

  91. Moldofsky H, Harris HW, Archambault WT, Kwong T, Lederman S. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study. J Rheumatol. 2011;38:2653–63.

    Article  CAS  PubMed  Google Scholar 

  92. Arnold LM. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med. 2007;8(Suppl 2):S63–74.

    Article  PubMed  Google Scholar 

  93. Gendreau RM, Thorn MD, Gendreau JF, Kranzler JD, Ribeiro S, Gracely RH, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005;32:1975–85.

    CAS  PubMed  Google Scholar 

  94. Bossini L, Coluccia A, Casolaro I, Benbow J, Amodeo G, De Giorgi R, et al. Off-label trazodone prescription: evidence, benefits and risks. Curr Pharm Des. 2015;21:3343–51.

    Article  CAS  PubMed  Google Scholar 

  95. Lewis SC, Bhattacharya S, Wu O, Vincent K, Jack SA, Critchley HOD, et al. Gabapentin for the management of chronic pelvic pain in women (GaPP1): a pilot randomised controlled trial. PLoS One. 2016;11:e0153037.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Häuser W, Bernardy K, Uçeyler N, Sommer C. Treatment of fibromyalgia syndrome with gabapentin and pregabalin–a meta-analysis of randomized controlled trials. Pain. 2009;145:69–81.

    Article  PubMed  CAS  Google Scholar 

  97. Moore RA, Wiffen PJ, Derry S, Toelle T, Rice ASC. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014;(4):CD007938.

  98. Bhattacharya A, Wickenden AD, Chaplan SR. Sodium channel blockers for the treatment of neuropathic pain. Neurotherapeutics. 2009;6:663–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Muehlbacher M, Nickel MK, Kettler C, et al. Topiramate in treatment of patients with chronic low back pain: a randomized, double-blind, placebo-controlled study. Clin J Pain. 2006;22:526–31.

    Article  PubMed  Google Scholar 

  100. Rogalski MJ, Kellogg-Spadt S, Hoffmann AR, Fariello JY, Whitmore KE. Retrospective chart review of vaginal diazepam suppository use in high-tone pelvic floor dysfunction. Int Urogynecol J. 2010;21:895–9.

    Article  PubMed  Google Scholar 

  101. Carrico DJ, Peters KM. Vaginal diazepam use with urogenital pain/pelvic floor dysfunction: serum diazepam levels and efficacy data. Urol Nurs. 2011;31(279–84):299.

    Google Scholar 

  102. Poli-Neto OB, Filho AA, Rosa e Silva JC, Barbosa Hde F, Candido Dos Reis FJ, Nogueira AA. Increased capsaicin receptor TRPV1 in the peritoneum of women with chronic pelvic pain. Clin J Pain. 2009;25:218–22.

    Article  PubMed  Google Scholar 

  103. Rocha MG, e Silva JCR, Ribeiro da Silva A, Candido Dos Reis FJ, Nogueira AA, Poli-Neto OB. TRPV1 expression on peritoneal endometriosis foci is associated with chronic pelvic pain. Reprod Sci. 2011;18:511–5.

    Article  CAS  PubMed  Google Scholar 

  104. Turini D, Beneforti P, Spinelli M, Malagutti S, Lazzeri M. Heat/burning sensation induced by topical application of capsaicin on perineal cutaneous area: new approach in diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome? Urology. 2006;67:910–3.

    Article  PubMed  Google Scholar 

  105. Theile JW, Cummins TR. Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes. Front Pharmacol. 2011;2:54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Dressler D, Adib Saberi F. Botulinum toxin: mechanisms of action. Eur Neurol. 2005;53:3–9.

    Article  CAS  PubMed  Google Scholar 

  107. Kim D-W, Lee S-K, Ahnn J. Botulinum toxin as a pain killer: players and actions in antinociception. Toxins. 2015;7:2435–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Arezzo JC. Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain. 2002;18:S125–32.

    Article  PubMed  Google Scholar 

  109. Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol. 2004;44:46–50.

    Article  PubMed  Google Scholar 

  110. Flynn TC, Clark RE 2nd. Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion. Dermatol Surg 2003;29:519–22 (discussion 522).

  111. Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108:915–23.

    Article  PubMed  Google Scholar 

  112. Morrissey D, El-Khawand D, Ginzburg N, Wehbe S, O’Hare P 3rd, Whitmore K. Botulinum toxin A injections into pelvic floor muscles under electromyographical guidance for women with refractory high-tone pelvic floor dysfunction: a 6-month prospective pilot study. Female Pelvic Med Reconstr Surg. 2015;21:277–82.

    Article  PubMed  Google Scholar 

  113. Santos J, Alarcão J, Fareleira F, Vaz-Carneiro A, Costa J. Tapentadol for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2015;(5):CD009923.

  114. Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33:451–9.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Younger J, Noor N, McCue R, Mackey S. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 2013;65:529–38.

    Article  CAS  PubMed  Google Scholar 

  116. Moulin D, Boulanger A, Clark AJ, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag. 2014;19:328–35.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Walczak JS, Price TJ, Cervero F. Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity. Neuroscience. 2009;159:1154–63.

    Article  CAS  PubMed  Google Scholar 

  118. Mukerji G, Yiangou Y, Agarwal SK, Anand P. Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms. Urology. 2010;75(1514):e15–20.

    Google Scholar 

  119. Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011;72:735–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Walitt B, Klose P, Fitzcharles M-A, Phillips T, Häuser W. Cannabinoids for fibromyalgia. Cochrane Database Syst Rev. 2016;(7):CD011694.

  121. Dutta A, McKie S, Deakin JFW. Ketamine and other potential glutamate antidepressants. Psychiatry Res. 2015;225:1–13.

    Article  CAS  PubMed  Google Scholar 

  122. McRoberts JA, Coutinho SV, Marvizón JC, et al. Role of peripheral N-methyl-d-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology. 2001;120:1737–48.

    Article  CAS  PubMed  Google Scholar 

  123. Serra G, Demontis F, Serra F, De Chiara L, Spoto A, Girardi P, et al. Memantine: new prospective in bipolar disorder treatment. World J Psychiatry. 2014;4:80–90.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Krystal JH. N-Methyl-d-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants. Arch Gen Psychiatry. 2010;67:1110–1.

    Article  PubMed  Google Scholar 

  125. John JP, Lukose A, Manjunath S. Off-label use of memantine as adjunctive treatment in schizophrenia: a retrospective case series study. Pharmacopsychiatry. 2014;47:202–9.

    Article  CAS  PubMed  Google Scholar 

  126. Morel V, Etienne M, Wattiez A-S, Dupuis A, Privat A-M, Chalus M, et al. Memantine, a promising drug for the prevention of neuropathic pain in rat. Eur J Pharmacol. 2013;721:382–90.

    Article  CAS  PubMed  Google Scholar 

  127. Nickel JC, Atkinson G, Krieger JN, Mills IW, Pontari M, Shoskes DA, et al. Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis/chronic pelvic pain syndrome. Urology. 2012;80:1105–10.

    Article  PubMed  Google Scholar 

  128. Nickel JC, Mills IW, Crook TJ, Jorga A, Smith MD, Atkinson G, et al. Tanezumab reduces pain in women with interstitial cystitis/bladder pain syndrome and patients with neurological associated somatic syndromes. J Urol. 2016;195:942–8.

    Article  CAS  PubMed  Google Scholar 

  129. Barcena de Arellano ML, Arnold J, Vercellino F, Chiantera V, Schneider A, Mechsner S. Overexpression of nerve growth factor in peritoneal fluid from women with endometriosis may promote neurite outgrowth in endometriotic lesions. Fertil Steril. 2011;95:1123–6.

    Article  CAS  PubMed  Google Scholar 

  130. Kajitani T, Maruyama T, Asada H, Uchida H, Oda H, Uchida S, et al. Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis. Endocr J. 2013;60:1155–64.

    Article  CAS  PubMed  Google Scholar 

  131. Chen W, Ye D-Y, Han D-J, Fu G-Q, Zeng X, Lin W, et al. Elevated level of nerve growth factor in the bladder pain syndrome/interstitial cystitis: a meta-analysis. Springerplus. 2016;5:1072.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  132. Tommola P, Unkila-Kallio L, Paetau A, Meri S, Kalso E, Paavonen J. Immune activation enhances epithelial nerve growth in provoked vestibulodynia. Am J Obstet Gynecol. 2016;215(6):768.e1–768.e8.

  133. Hochberg MC, Tive LA, Abramson SB, Vignon E, Verburg KM, West CR, et al. When is osteonecrosis not osteonecrosis? Adjudication of reported serious adverse joint events in the tanezumab clinical development program. Arthritis Rheumatol. 2016;68:382–91.

    Article  CAS  PubMed  Google Scholar 

  134. Badawy SZA, Brown S, Kaufman L, Wojtowycz MA. Aromatase inhibitor (anastrozole) affects growth of endometrioma cells in culture. Eur J Obstet Gynecol Reprod Biol. 2015;188:45–50.

    Article  CAS  PubMed  Google Scholar 

  135. Abushahin F, Goldman KN, Barbieri E, Milad M, Rademaker A, Bulun SE. Aromatase inhibition for refractory endometriosis-related chronic pelvic pain. Fertil Steril. 2011;96:939–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Almassinokiani F, Almasi A, Akbari P, Saberifard M. Effect of letrozole on endometriosis-related pelvic pain. Med J Islam Repub Iran. 2014;28:107.

    PubMed  PubMed Central  Google Scholar 

  137. Soysal S, Soysal ME, Ozer S, Gul N, Gezgin T. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod. 2004;19:160–7.

    Article  PubMed  Google Scholar 

  138. Ferrero S, Gillott DJ, Venturini PL, Remorgida V. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod Biol Endocrinol. 2011;9:89.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Nawathe A, Patwardhan S, Yates D, Harrison GR, Khan KS. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG. 2008;115:818–22.

    Article  CAS  PubMed  Google Scholar 

  140. Diamond MP, Carr B, Dmowski WP, Koltun W, O’Brien C, Jiang P, et al. Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study. Reprod Sci. 2014;21:363–71.

    Article  PubMed  CAS  Google Scholar 

  141. Goldfinger C, Pukall CF, Thibault-Gagnon S, McLean L, Chamberlain S. Effectiveness of cognitive-behavioral therapy and physical therapy for provoked vestibulodynia: a randomized pilot study. J Sex Med. 2016;13:88–94.

    Article  PubMed  Google Scholar 

  142. Fitzgerald MP, Anderson RU, Potts J, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2013;189:S75–85.

    Article  PubMed  Google Scholar 

  143. FitzGerald MP, Kotarinos R. Rehabilitation of the short pelvic floor. II: treatment of the patient with the short pelvic floor. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:269–75 (discussion 275).

  144. Liu L, Huang Q-M, Liu Q-G, Ye G, Bo C-Z, Chen M-J, et al. Effectiveness of dry needling for myofascial trigger points associated with neck and shoulder pain: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2015;96:944–55.

    Article  PubMed  Google Scholar 

  145. Cerezo-Téllez E, Torres-Lacomba M, Fuentes-Gallardo I, Perez-Muñoz M, Mayoral-Del-Moral O, Lluch-Girbés E, et al. Effectiveness of dry needling for chronic nonspecific neck pain: a randomized, single-blinded, clinical trial. Pain. 2016;157:1905–17.

    Article  PubMed  Google Scholar 

  146. Williams DA, Cary MA, Groner KH, Chaplin W, Glazer LJ, Rodriguez AM, et al. Improving physical functional status in patients with fibromyalgia: a brief cognitive behavioral intervention. J Rheumatol. 2002;29:1280–6.

    PubMed  Google Scholar 

  147. Williams DA, Kuper D, Segar M, Mohan N, Sheth M, Clauw DJ. Internet-enhanced management of fibromyalgia: a randomized controlled trial. Pain. 2010;151:694–702.

    Article  PubMed  PubMed Central  Google Scholar 

  148. Bernardy K, Klose P, Busch AJ, Choy EHS, Häuser W. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013;(9):CD009796.

  149. van Koulil S, van Lankveld W, Kraaimaat FW, et al. Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia. Arthritis Care Res. 2010;62:1377–85.

    Article  Google Scholar 

  150. Glombiewski JA, Sawyer AT, Gutermann J, Koenig K, Rief W, Hofmann SG. Psychological treatments for fibromyalgia: a meta-analysis. Pain. 2010;151:280–95.

    Article  PubMed  Google Scholar 

  151. Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U. Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother Psychosom. 2007;76:226–33.

    Article  PubMed  Google Scholar 

  152. Monteiro ÉS, de Carvalho LBC, Fukujima MM, Lora MI, do Prado GF. Electrical stimulation of the posterior tibialis nerve improves symptoms of poststroke neurogenic overactive bladder in men: a randomized controlled trial. Urology. 2014;84:509–14.

    Article  PubMed  Google Scholar 

  153. Wibisono E, Rahardjo HE. Effectiveness of short term percutaneous tibial nerve stimulation for non-neurogenic overactive bladder syndrome in adults: a meta-analysis. Acta Med Indones. 2015;47:188–200.

    PubMed  Google Scholar 

  154. Proctor ML, Smith CA, Farquhar CM, Stones RW. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea. Cochrane Database Syst Rev. 2002;(1):CD002123.

  155. Gozani SN. Fixed-site high-frequency transcutaneous electrical nerve stimulation for treatment of chronic low back and lower extremity pain. J Pain Res. 2016;9:469–79.

    Article  PubMed  PubMed Central  Google Scholar 

  156. Sierakowski A, Jing SS, Poel J, Elliot D. Transcutaneous peripheral nerve stimulation for the treatment of neuropathic pain in the upper limb. J Hand Surg Asian Pac. 2016;21:37–43.

    Article  CAS  Google Scholar 

  157. Iodice P, Lessiani G, Franzone G, Pezzulo G. Efficacy of pulsed low-intensity electric neuromuscular stimulation in reducing pain and disability in patients with myofascial syndrome. J Biol Regul Homeost Agents. 2016;30:615–20.

    CAS  PubMed  Google Scholar 

  158. Upton GA, Tinley P, Al-Aubaidy H, Crawford R. The influence of transcutaneous electrical nerve stimulation parameters on the level of pain perceived by participants with painful diabetic neuropathy: a crossover study. Diabetes Metab Syndr. 2016. doi:10.1016/j.dsx.2016.08.016 (Epub 23 Aug 2016).

  159. Ellrich J, Lamp S. Peripheral nerve stimulation inhibits nociceptive processing: an electrophysiological study in healthy volunteers. Neuromodulation. 2005;8:225–32.

    Article  PubMed  Google Scholar 

  160. Kocyigit F, Akalin E, Gezer NS, Orbay O, Kocyigit A, Ada E. Functional magnetic resonance imaging of the effects of low-frequency transcutaneous electrical nerve stimulation on central pain modulation: a double-blind, placebo-controlled trial. Clin J Pain. 2012;28:581–8.

    Article  PubMed  Google Scholar 

  161. Valovska A, Peccora CD, Philip CN, Kaye AD, Urman RD. Sacral neuromodulation as a treatment for pudendal neuralgia. Pain Physician. 2014;17:E645–50.

    PubMed  Google Scholar 

  162. Peters KM, Killinger KA, Jaeger C, Chen C. Pilot study exploring chronic pudendal neuromodulation as a treatment option for pain associated with pudendal neuralgia. Low Urin Tract Symptoms. 2015;7:138–42.

    Article  PubMed  Google Scholar 

  163. Fenton BW, Palmieri PA, Boggio P, Fanning J, Fregni F. A preliminary study of transcranial direct current stimulation for the treatment of refractory chronic pelvic pain. Brain Stimul. 2009;2:103–7.

    Article  PubMed  Google Scholar 

  164. Simis M, Reidler JS, Duarte Macea D, Moreno Duarte I, Wang X, Lenkinski R, et al. Investigation of central nervous system dysfunction in chronic pelvic pain using magnetic resonance spectroscopy and noninvasive brain stimulation. Pain Pract. 2015;15:423–32.

    Article  PubMed  Google Scholar 

  165. Marziali M, Venza M, Lazzaro S, Lazzaro A, Micossi C, Stolfi VM. Gluten-free diet: a new strategy for management of painful endometriosis related symptoms? Minerva Chir. 2012;67:499–504.

    CAS  PubMed  Google Scholar 

  166. Slim M, Calandre EP, Garcia-Leiva JM, Rico-Villademoros F, Molina-Barea R, Rodriguez-Lopez CM, et al. The effects of a gluten-free diet versus a hypocaloric diet among patients with fibromyalgia experiencing gluten sensitivity-like symptoms: a pilot, open-label randomized clinical trial. J Clin Gastroenterol. 2016. doi:10.1097/MCG.0000000000000651 (Epub 19 Aug 2016).

  167. Pattanittum P, Kunyanone N, Brown J, Sangkomkamhang US, Barnes J, Seyfoddin V, et al. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev. 2016;(3):CD002124.

  168. Bassaly R, Downes K, Hart S. Dietary consumption triggers in interstitial cystitis/bladder pain syndrome patients. Female Pelvic Med Reconstr Surg. 2011;17:36–9.

    Article  PubMed  Google Scholar 

  169. Elli L, Tomba C, Branchi F, et al. Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: results from a multicenter randomized double-blind placebo-controlled gluten challenge. Nutrients. 2016;8:84.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  170. Gearry R, Skidmore P, O’Brien L, Wilkinson T, Nanayakkara W. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016;9:131–42.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, 4010 Old Clinic Building, CB 7570, Chapel Hill, NC, 27599-7570, USA

    Erin T. Carey

  2. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA

    Sara R. Till & Sawsan As-Sanie

Authors
  1. Erin T. Carey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sara R. Till
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sawsan As-Sanie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erin T. Carey.

Ethics declarations

Conflict of interest

Erin T. Carey has appeared as an expert witness (plaintiff mesh litigation); Sawsan As-Sanie is a consultant for Myriad Genetics and Daiichi Sankyo; Sara R. Till has no conflicts of interest to declare.

Funding

The authors report no external funding.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carey, E.T., Till, S.R. & As-Sanie, S. Pharmacological Management of Chronic Pelvic Pain in Women. Drugs 77, 285–301 (2017). https://doi.org/10.1007/s40265-016-0687-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40265-016-0687-8

Keywords

Search

Navigation